• 1
    Roberts RO, Jacobsen SJ, Jacobson DJ, Reilly WT, Talley NJ, Lieber MM. Natural history of prostatism: high American Urological Association Symptom scores among community-dwelling men and women with urinary incontinence. Urology 1994; 43: 6218
  • 2
    Roehrborn CG, McConnell J, Bonilla J et al. Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. PROSCAR long-term efficacy and safety study. J Urol 2000; 163: 1320
  • 3
    Wasson JH, Reda DJ, Bruskewitz RC, Elinson J, Keller AM, Henderson WG. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate. N Engl J Med 1995; 332: 759
  • 4
    AUA Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia. Chapter 1: Diagnosis and treatment recommendations. J Urol 2003; 170: 53074
  • 5
    Gee WF, Holtgrewe HL, Albertsen PC et al. Practice trends in the diagnosis and management of benign prostatic hyperplasia in the United States. J Urol 1995; 154: 2056
  • 6
    McCullough DL. Minimally invasive treatment of benign prostatic hyperplasia. In WalshP, RetikAB, VaughanED, WeinA eds, Campbell's Urology, Vol. 2, 7th edn. Philadelphia: WB Saunders, 1998: 1479–509
  • 7
    Botto H, Lebret T, Barre P, Orsoni JL, Herve JM, Lugagne PM. Electrovaporization of the prostate with the Gyrus device. J Endourol 2001; 15: 3136
  • 8
    Dunsmuir WD, McFarlane JP, Tan A et al. Gyrus bipolar electrovaporization vs transurethral resection of the prostate: a randomized prospective single-blind trial with 1 y follow-up. Prostate Cancer Prostatic Dis 2003; 6: 1826
  • 9
    Nesbit RM. Transurethral Prostatectomy. Springfield IL: CC Thomas, 1943
  • 10
    Perrin P, Barnes R, Hadley H, Bergman RT. Forty years of transurethral prostatic resections. J Urol 1976; 116: 7578